530 related articles for article (PubMed ID: 31016455)
1. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
[TBL] [Abstract][Full Text] [Related]
2. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
[TBL] [Abstract][Full Text] [Related]
3. Visual Liver Score to Stratify Non-Alcoholic Steatohepatitis Risk and Determine Selective Intraoperative Liver Biopsy in Obesity.
Ooi GJ; Burton PR; Earnest A; Laurie C; Kemp WW; Nottle PD; McLean CA; Roberts SK; Brown WA
Obes Surg; 2018 Feb; 28(2):427-436. PubMed ID: 28776153
[TBL] [Abstract][Full Text] [Related]
4. Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese.
Ooi GJ; Burton PR; Doyle L; Wentworth JM; Bhathal PS; Sikaris K; Cowley MA; Roberts SK; Kemp W; O'Brien PE; Brown WA
Obes Surg; 2017 Jan; 27(1):115-125. PubMed ID: 27220852
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
6. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems.
Schmitz SM; Kroh A; Ulmer TF; Andruszkow J; Luedde T; Brozat JF; Neumann UP; Alizai PH
BMC Gastroenterol; 2020 Aug; 20(1):254. PubMed ID: 32758151
[TBL] [Abstract][Full Text] [Related]
8. Measurement of Liver Stiffness with 2D-Shear Wave Elastography (2D-SWE) in Bariatric Surgery Candidates Reveals Acceptable Diagnostic Yield Compared to Liver Biopsy.
Jamialahmadi T; Nematy M; Jangjoo A; Goshayeshi L; Rezvani R; Ghaffarzadegan K; Nooghabi MJ; Shalchian P; Zangui M; Javid Z; Doaei S; Rajabzadeh F
Obes Surg; 2019 Aug; 29(8):2585-2592. PubMed ID: 31077025
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity.
Meneses D; Olveira A; Corripio R; Méndez MDC; Romero M; Calvo-Viñuelas I; Herranz L; Vicent D; de-Cos-Blanco AI
Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):178-188. PubMed ID: 35396116
[TBL] [Abstract][Full Text] [Related]
10. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
Yeo SC; Ong WM; Cheng KSA; Tan CH
Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.
Morita S; Neto Dde S; Morita FH; Morita NK; Lobo SM
Obes Surg; 2015 Dec; 25(12):2335-43. PubMed ID: 25920616
[TBL] [Abstract][Full Text] [Related]
12. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.
Wolter S; Duprée A; Coelius C; El Gammal A; Kluwe J; Sauer N; Mann O
Obes Surg; 2017 Jan; 27(1):90-95. PubMed ID: 27272667
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes.
Lembo E; Russo MF; Verrastro O; Anello D; Angelini G; Iaconelli A; Guidone C; Stefanizzi G; Ciccoritti L; Greco F; Sessa L; Riccardi L; Pompili M; Raffaelli M; Vecchio FM; Bornstein SR; Mingrone G; Gastaldelli A; Capristo E
Diabetes Metab; 2022 Sep; 48(5):101363. PubMed ID: 35760372
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
[TBL] [Abstract][Full Text] [Related]
16. Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.
Ayres ABS; Carneiro CRG; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2024 Feb; 34(2):456-466. PubMed ID: 38097891
[TBL] [Abstract][Full Text] [Related]
17. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
Qureshi K; Abrams GA
Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
[TBL] [Abstract][Full Text] [Related]
19. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
20. Utility of Ultrasound, Transaminases, and Visual Inspection to Assess Nonalcoholic Fatty Liver Disease in Bariatric Surgery Patients.
Petrick A; Benotti P; Wood GC; Still CD; Strodel WE; Gabrielsen J; Rolston D; Chu X; Argyropoulos G; Ibele A; Gerhard GS
Obes Surg; 2015 Dec; 25(12):2368-75. PubMed ID: 26003548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
